Proteon Therapeutics and ArTara Therapeutics Agree to Combine
23 sept. 2019 16h20 HE
|
Proteon Therapeutics, Inc.
Transaction to Create NASDAQ-Listed Rare and Specialty Disease Therapeutic Company Focused on Immunology and Metabolic Disorders $42.5M Concurrent Financing to be Led by a Syndicate of Healthcare...
Proteon Therapeutics Announces Second Quarter 2019 Financial Results
07 août 2019 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company that has historically focused on the development of novel, first-in-class pharmaceuticals to...
Quanta Supports the American Kidney Health Initiative
11 juil. 2019 10h24 HE
|
Quanta Dialysis Technologies
Quanta Supports the American Kidney Health Initiative Alcester, UK, 11 July 2019: A major overhaul of American kidney health was announced yesterday by the Trump Administration and the US...
Proteon Therapeutics Announces First Quarter 2019 Financial Results
08 mai 2019 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Nephros to Present at Taglich Brothers 16th Annual Investment Conference on April 30, 2019 in New York City
24 avr. 2019 07h30 HE
|
Nephros, Inc.
SOUTH ORANGE, NJ, April 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc.(OTCQB: NEPH), a commercial stage company that develops and sells high performance liquid purification filters...
Proteon Therapeutics Announces Review of Potential Strategic Transactions
15 avr. 2019 16h30 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas
28 mars 2019 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 28, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
LogistiCare Raises Public Awareness during National Kidney Month
19 mars 2019 11h45 HE
|
LogistiCare
ATLANTA, March 19, 2019 (GLOBE NEWSWIRE) -- In the United States, more than 661,000 people suffer from kidney failure. Of these, 468,000 individuals are on dialysis, and roughly 193,000 live with a...
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
13 mars 2019 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
12 mars 2019 07h45 HE
|
Nephros, Inc.
Annual Product Revenues Up 54% SOUTH ORANGE, N.J., March 12, 2019 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid...